CLM SAP Edition 14 Evaluation and Management of Familial Hypercholesterolemia

Curriculum:
N/A
Credits:
3 ACPE 3 ANCC Contract Hours 3 CDR 3 AMA PRA Category 1 Credit(s)™
Launch Date:
15-Jul-12
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

No primary audience was provided.

Relevant Terms:

No primary audience was provided.

See Faculty section below for a complete list of faculty.

See Faculty section below for a complete list of faculty.

1. Describe the prevalence and associated risk of familial hypercholesterolemia, in order to increase awareness and understanding of the disease;
2. Illustrate the importance of universal screening during childhood and cascade lipid screening of family members of known FH patients;
3. Differentiate management strategies that improve the care of patients with FH and reduce their elevated risk of CHD;
4. Evaluate the clinical effects, safety and efficacy data for current and new treatment options for FH patients;
5. Implement evidence-based treatment options for screening, diagnosing and treating FH in both pediatric and adult patients (including women of childbearing potential and during pregnancy).